Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Readers of this article should be aware that the Health Product Profile Directory (https://www.who.int/tdr/diseases-topics/product-directory/en/) is a free-to-use online resource created and developed by TDR on behalf of WHO as a global public good to improve the efficiency of efforts to develop new products for neglected diseases and populations as well as threats to global health. It provides a searchable database of the 8-10 key characteristics used to describe desired health products, including medicines, vaccines, diagnostics and medical equipment. Links are provided to access the full Product Profile document where this is publicly available. The Directory was launched in May 2019 and will be continuously updated. Users should read the FAQ and user instructions document for full background information.
Re: Targeted health innovation for global health - a link to the Directory
Readers of this article should be aware that the Health Product Profile Directory (https://www.who.int/tdr/diseases-topics/product-directory/en/) is a free-to-use online resource created and developed by TDR on behalf of WHO as a global public good to improve the efficiency of efforts to develop new products for neglected diseases and populations as well as threats to global health. It provides a searchable database of the 8-10 key characteristics used to describe desired health products, including medicines, vaccines, diagnostics and medical equipment. Links are provided to access the full Product Profile document where this is publicly available. The Directory was launched in May 2019 and will be continuously updated. Users should read the FAQ and user instructions document for full background information.
Competing interests: No competing interests